Shanghai Henlius Biotech (HKG:2696) dosed the first patient in a Phase 1 clinical trial of HLX316 for injection, according to a Friday Hong Kong bourse filing.
The trial is studying the effects of the drug in patients with advanced/metastatic solid tumors in Mainland China.
Winbond Electronics (TPE:2344) will procure machinery equipment worth about NT$2.3 billion from Applied Materials, according to a Thursday Taiwan Exchange filing.Shares jumped about 10% in Friday's late morning trade.The equipment will be used for for production purposes, it said.
CapitaLand Ascendas REIT (SGX:A17U) along with CapitaLand Development, launched Geneo, a SG$1.4 billion life sciences and innovation hub at Singapore Science Park, according to a Friday filing with the Singapore Exchange.Geneo spans across an area of 180,600 square meters and comprises three properties, which include laboratories and business park workspaces.
China Bohai Bank (HKG:9668) completed the issuance of 9 billion yuan in tier 2 capital bonds in China's interbank bond market, according to a Thursday Hong Kong bourse filing.Shares of the lender were up more than 1% in late morning trade on Friday.The bonds are 10-year fixed-rate notes with an issuer redemption option at the end of the fifth year and carry a coupon rate of 2.10%.The bank said proceeds from the issuance will be used entirely to replenish its tier 2 capital.